Tim advises clients in contentious IP matters across a wide range of technologies, especially disputes having an international element and in the pharmaceutical sector.

Tim advises on contentious matters across all IP rights, with a strong focus on patent litigation and strategy. He represents clients in cases before the English Courts, as well as in proceedings before the European Patent Office. He has very extensive experience of advising clients on the co-ordination of international patent litigation strategy including in the pharmaceutical, medical devices and electronics fields. Tim also advises on related issues arising from international technology standards, patent pools and licensing, as well as pharmaceutical regulatory issues and SPCs.

Tim’s strong scientific background allows him readily to understand complex technical issues. He has advised on patents and litigation strategy relating to a diverse range of technologies, including pharmaceutical and biotechnology products and formulations, medical devices and associated consumables, telecommunications (both implementation patents and those declared essential to telecommunications standards), industrial processes and consumer electronics.

Tim also has experience of patent portfolio due diligence projects, contentious design right issues and trade mark infringement disputes. 

Tim joined Powell Gilbert as an associate when it was founded in 2007, and became a partner in 2012.

Key cases

  • Accord Healthcare v Research Corporation Technologies (anti-epileptics)

  • ​Napp v Sandoz & Dr Reddy’s (buprenorphine transdermal patches)

  • Elekta v Varian (radiotherapy treatment control systems)

  • Varian v Elekta (MRI/radiotherapy devices)

  • Merck v Royalty Pharma (Type 2 diabetes treatments)

  • Unwired Planet v Huawei & Others (telecommunications)

  • Fresenius v Advanced Renal Technologies (dialysis fluids)

  • Baxter v Fresenius (medical devices)

  • Motorola Mobility v BT (digital TV)

  • Microsoft v Motorola Mobility (smartphones)

  • Corma v Hegler Plastik (extruded plastics)

  • Fresenius v CareFusion (medical devices)

  • Nuance v Vlingo (speech recognition)

  • Philips & Others v Alba (MPEG-2 / FRAND licensing)

  • Sandoz / ratiopharm v Napp (controlled release oxycodone formulations)

  • Aveva v LTS (nicotine transdermal patches) 

  • Tupperware v Lékué (silicone products)